for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

CareDx Inc

CDNA.O

Latest Trade

42.32USD

Change

-0.05(-0.12%)

Volume

184,433

Today's Range

40.76

 - 

43.06

52 Week Range

39.16

 - 

99.83

As of on the NASDAQ ∙ Minimum 15 minute delay

Latest News

BRIEF-New Kidney360 Publication Highlights Caredx’S Allosure Is Differentiated As The Dd-Cfdna Test Of Choice

* NEW KIDNEY360 PUBLICATION HIGHLIGHTS CAREDX’S ALLOSURE IS DIFFERENTIATED AS THE DD-CFDNA TEST OF CHOICE

BRIEF-Caredx Files Preliminary Prospectus Supplement Related To $100 Mln Common Stock Offering - SEC Filing

* CAREDX FILES PRELIMINARY PROSPECTUS SUPPLEMENT RELATED TO $100 MILLION COMMON STOCK OFFERING - SEC FILING Source : (https://bit.ly/37nRhjC) Further company coverage:

BRIEF-Caredx's Alloseq Tx 17 Awarded CE Mark Approval

* CAREDX'S ALLOSEQ TX 17 AWARDED CE MARK APPROVAL Source text for Eikon: Further company coverage:

BRIEF-Caredx And Veracyte Announce Partnership For Transplant Rejection Testing On Ncounter System

* CAREDX AND VERACYTE ANNOUNCE EXCLUSIVE PARTNERSHIP FOR TRANSPLANT REJECTION TESTING ON NCOUNTER SYSTEM

BRIEF-CareDx Says Withdrew Previously Issued Full Year 2020 Revenue Guidance

* CAREDX REPORTS PRELIMINARY FIRST QUARTER 2020 REVENUE AND PROVIDES BUSINESS UPDATE IN RESPONSE TO COVID-19 PANDEMIC

BRIEF-CareDx Posts Q4 Non-GAAP Earnings Per Share Of $0.04

* Q4 REVENUE $35.8 MILLION VERSUS REFINITIV IBES ESTIMATE OF $35.8 MILLION

BRIEF-Caredx's Patent Rights Upheld By Delaware Court

* CAREDX - COURT RECOMMENDED DENIAL OF NATERA INC.'S & EUROFINS VIRACOR INC.'S MOTIONS TO DISMISS CAREDX'S PATENT INFRINGEMENT COMPLAINTS AGAINST THEM

IN BRIEF: Judge won’t dismiss patent suit over Natera’s kidney transplant rejection test

A patent infringement lawsuit by Stanford University and licensee CareDx Inc against genetic testing company Natera Inc survived a motion to dismiss on Tuesday in U.S. District Court in Delaware.

CareDx adds false advertising claims to patent dispute with Natera

Medical diagnostics company CareDx Inc on Wednesday escalated a legal battle with rival Natera Inc over kidney transplant technology, adding false advertising claims in a new lawsuit to what began as a patent dispute.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up